Market Expansion Reach Separations' focus on providing high-quality chromatography services to pharmaceutical, agrochemical, and fine chemical sectors presents a significant opportunity to engage with companies across these industries that require efficient small molecule analysis and purification solutions.

Strategic Acquisition The recent acquisition by CatSci Ltd enhances Reach Separations’ capabilities by integrating end-to-end separation science support, creating cross-selling opportunities for advanced separation technologies and comprehensive project workflows.

Technology Utilization Utilizing the latest HPLC and SFC technologies, Reach Separations can appeal to clients seeking cutting-edge analytical solutions, especially those involved in complex chiral separations, highlighting opportunities for sales of specialized instrumentation or technical services.

Growth Potential With a revenue range of up to $10 million and a relatively small workforce, Reach Separations is positioned as an agile partner open to expanding its service portfolio, offering prospects for additional specialized tests, custom solutions, or collaborative innovations.

Niche Focus As experts in chiral separation serving a diverse client base across the UK and Europe, Reach Separations presents an opportunity to target pharmaceutical companies and biotech firms that require precise enantiomeric purity analysis, potentially increasing sales of high-value, specialized separation services.